Evan M. Hersh - Concepedia

Author

Evan M. Hersh

Anderson Hospital

Also Known As

E Hersh, E M Hersh, EVAN M. HERSH, EVan M. Hersh, Evan Hersh, Evan M Hersh, Evan M. Hersh, EvanM. Hersh

283

Publications

15.7K

Citations

H-Index

205

Concepts

All Affiliations

Anderson Hospital The University of Texas MD Anderson Cancer Center University of Arizona The University of Texas System Arizona Oncology

About

Evan M. Hersh is an author at Anderson Hospital specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	118	7.8K
2	Health Sciences	14	15	1K
3	Natural Sciences	6	6	2K
4	Engineering	2	2	112
5	Public Health	2	2	87

Evan M. Hersh

174

Publications

14.3K

Citations

H-Index

Page 1

	Year	Citations
A new type of synthetic peptide library for identifying ligand-binding activity Kit S. Lam, Sydney E. Salmon, Evan M. Hersh, Nature Medicinal ChemistryBiochemistryNew TypeNatural SciencesPeptide Engineering	1991	1.8K
Non-Hodgkin's Lymphoma in 90 Homosexual Men John L. Ziegler, Jay A. Beckstead, Paul A. Volberding, New England Journal of Medicine ImmunodeficienciesImmunologyPathologyHomosexualityQueer Theory	1984	981
Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia Jorge R. Quesada, James M. Reuben, John T. Manning, New England Journal of Medicine	1984	834
Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group Agop Y. Bedikian, Michael Millward, Hubert Pehamberger, Journal of Clinical Oncology	2006	596
Causes of Death in Acute Leukemia Evan M. Hersh JAMA Hematological MalignancyFatal HemorrhageMedicinePathogenesisHematology	1965	497
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma Jeffrey S. Weber, Steven O’Day, Walter J. Urba, Journal of Clinical Oncology	2008	460
Impaired in Vitro Lymphocyte Transformation in Hodgkin's Disease Evan M. Hersh, Joost J. Oppenheim New England Journal of Medicine Laboratory ImmunologyLymphocyte DevelopmentImmunodeficienciesImmunologyImmune Regulation	1965	379
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma Evan M. Hersh, Steven O’Day, John D. Powderly, Investigational New Drugs Chemotherapy-naïve PatientsMedicineMelanomaPharmacologyImmune Checkpoint Inhibitor	2010	302
Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies David Nyman, Kimberley J. Campbell, Evan M. Hersh, Journal of Clinical Oncology	2005	279
Macrophage-Lymphocyte Interaction in the Antigen-Induced Blastogenic Response of Human Peripheral Blood Leukocytes, Evan M. Hersh, Jules E. Harris The Journal of Immunology	1968	261

Page 1